Search results

Found 49 pages
AUTHOR: Claire Bowie

Results per page

10 20 50 100

Sort by

Relevance Date

24 Jan 2008:

GSK’s Avandia sees strengthened warning; EMEA

Europe’s drug regulator, the EMEA, is to strengthen labeling for GlaxoSmithKline’s antidiabetic drug Avandia (rosiglitazone) to recommend against its use in patients with ischemic heart disease and/or peripheral arterial disease. - News -

by Claire Bowie

https://www.pharmatimes.com/news/gsks_avandia_sees_strengthened_warning_emea_985915

20 Aug 2010:

US grants new lupus drug fast review

GlaxoSmithKline and Human Genome Sciences Benlysta (belimumab) has been awarded priority review status in the USA as a potential treatment for systemic lupus erythematosus. The target date for approval is 9 December 2010, six months after the

by Claire Bowie

https://www.pharmatimes.com/news/us_grants_new_lupus_drug_fast_review_982565

12 Aug 2008:

Cardiome tumbles on approvable letter for AF drug

Canadian biotechnology company Cardiome saw its share price tumble yesterday after the US drug regulator asked for more safety data for its atrial fibrillation drug Kynapid (vernakalant hydrochloride). - News - PharmaTimes

by Claire Bowie

https://www.pharmatimes.com/news/cardiome_tumbles_on_approvable_letter_for_af_drug_988084

17 Dec 2009:

Afferent launched with pain relief from Roche

New company Afferent Pharmaceuticals is hoping it will be the first off the block with a new kind of treatment for chronic pain after licensing Roche’s P2X3 receptor programme. - News - PharmaTimes

by Claire Bowie

https://www.pharmatimes.com/news/afferent_launched_with_pain_relief_from_roche_984088

3 Dec 2012:

Three pharma firms face wrath of the PMCPA

Three pharma firms have been held to account by the ABPI for breaching its Code of Practice and ‘bringing discredit’ upon the industry. - News - PharmaTimes

by Claire Bowie

https://www.pharmatimes.com/news/three_pharma_firms_face_wrath_of_the_pmcpa_976117

16 Nov 2009:

Guilford Pharmaceuticals Stockholders Vote to Approve MGI PHARMA…

Guilford Pharmaceuticals - News - PharmaTimes

by Claire Bowie

https://www.pharmatimes.com/news/guilford_pharmaceuticals_stockholders_vote_to_approve_mgi_pharma_merger_984269

24 Jan 2008:

Entereg boosted by FDA thumbs up

GlaxoSmithKline and partner Adolor will have been cheered yesterday after a US Food and Drug Administration advisory panel narrowly voted 9-6 that its mu-opioid receptor antagonist Entereg’s (alvimopan) benefits outweigh its risks. The news

by Claire Bowie

https://www.pharmatimes.com/news/entereg_boosted_by_fda_thumbs_up_985917

8 Oct 2009:

Novartis snaps up first in class antibiotic

Swiss giant Novartis has snapped up the rights to market a potentially first-in-class antibiotic from Paratek Pharmaceuticals for an undisclosed sum, bolstering the company's armamentarium in this field following its acquisition of Protez

by Claire Bowie

https://www.pharmatimes.com/news/novartis_snaps_up_first_in_class_antibiotic_984490

7 Oct 2009:

Pfizer's HIV drug set for expanded use in USA

Pfizer’s HIV medicine Selzentry (maraviroc) could significantly expand its market today to include treatment-naïve patients, if a US Food and Drug Administration panel takes heed of briefing documents posted on the agency’s website ahead of the

by Claire Bowie

https://www.pharmatimes.com/news/pfizers_hiv_drug_set_for_expanded_use_in_usa_983518

8 Sep 2011:

UK health reform moves to next step

The controversial healthcare reform bill has moved through the House of Commons with a majority of 65, and will now pass to the House of Lords for ratification. Despite the threat of LibDem opposition, only four voted against the Bill while 11

by Claire Bowie

https://www.pharmatimes.com/news/uk_health_reform_moves_to_next_step_980427